Vivimed Labs Limited (VIVIMEDLAB) Share Price & AI Investment Analysis

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It al. Track Vivimed Labs Limited's live NSE:VIVIMEDLAB share price ₹5.55 (+1.83%), market cap ₹₹46Cr. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for VIVIMEDLAB — real-time NSE India stock intelligence.